We have congregated information concerning stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Enterprise Products Partners L.P.
86.29% Payout Ratio
As maintained by Morningstar, Inc., the next dividend pay date is on Oct 28, 2020, the estimated forward annual dividend rate is 1.78 and the estimated forward annual dividend yield is 8.61%.
Enterprise Products Partners L.P. sales growth this year is anticipated to be negative 13.7% and 4% for next year.
Year-on-year quarterly revenue growth declined by 13.1%, now sitting on 28.16B for the twelve trailing months.
Enterprise Products Partners L.P.'s sales growth for the next quarter is a negative 4%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative -23%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.98%.
Enterprise Products Partners L.P.'s Stock Top and Bottom Yearly Value
Enterprise Products Partners L.P.'s stock is valued at $21.37 at 19:58 EST, way below its 52-week high of $29.22 and way above its 52-week low of $10.27.
Enterprise Products Partners L.P.'s Moving Average
Enterprise Products Partners L.P.'s value is way higher than its 50-day moving average of $18.54 and way above its 200-day moving average of $18.07.
2. Washington Real Estate Investment Trust
196.72% Payout Ratio
As claimed by Morningstar, Inc., the next dividend pay date is on Dec 21, 2020, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 5.22%.
Washington Real Estate Investment Trust sales growth this year is anticipated to be negative 4.7% and 2.7% for next year.
Year-on-year quarterly revenue growth declined by 8.8%, now sitting on 303.56M for the twelve trailing months.
Washington Real Estate Investment Trust's sales growth for the next quarter is a negative 5%. The company's growth estimates for the present quarter and the next is a negative 101.5% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.77%.
Washington Real Estate Investment Trust's Stock Top and Bottom Yearly Value
Washington Real Estate Investment Trust's stock is valued at $23.00 at 19:58 EST, way under its 52-week high of $32.22 and way higher than its 52-week low of $16.95.
Washington Real Estate Investment Trust's Moving Average
Washington Real Estate Investment Trust's value is higher than its 50-day moving average of $21.62 and higher than its 200-day moving average of $21.79.
3. Illinois Tool Works Inc.
66.01% Payout Ratio
As claimed by Morningstar, Inc., the next dividend pay date is on Dec 29, 2020, the estimated forward annual dividend rate is 4.56 and the estimated forward annual dividend yield is 2.21%.
Illinois Tool Works Inc. sales growth this year is expected to be negative 12.1% and 9.7% for next year.
Year-on-year quarterly revenue growth declined by 4.9%, now sitting on 12.57B for the twelve trailing months.
Illinois Tool Works Inc.'s sales growth for the next quarter is 3.9%. The company's growth estimates for the current quarter and the next is a negative 11.1% and 2.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 74.4%.
Illinois Tool Works Inc.'s Stock Top and Bottom Yearly Value
Illinois Tool Works Inc.'s stock is valued at $202.55 at 19:58 EST, below its 52-week high of $224.69 and way higher than its 52-week low of $115.94.
Illinois Tool Works Inc.'s Moving Average
Illinois Tool Works Inc.'s value is below its 50-day moving average of $206.45 and above its 200-day moving average of $192.02.
4. The Gabelli Healthcare & Wellness Trust
124.44% Payout Ratio
As claimed by Morningstar, Inc., the next dividend pay date is on Dec 9, 2020, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 5.14%.
The Gabelli Healthcare & Wellness Trust sales growth this year is expected to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on N/A for the twelve trailing months.
The Gabelli Healthcare & Wellness Trust's sales growth is a negative 0% for the ongoing quarter and negative 0% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is a negative 0%.
The Gabelli Healthcare & Wellness Trust's Stock Top and Bottom Yearly Value
The Gabelli Healthcare & Wellness Trust's stock is valued at $11.54 at 19:58 EST, under its 52-week high of $11.92 and way above its 52-week low of $6.85.
The Gabelli Healthcare & Wellness Trust's Moving Average
The Gabelli Healthcare & Wellness Trust's value is above its 50-day moving average of $10.99 and higher than its 200-day moving average of $10.57.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
